First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond,Karen Bolhuis,Olaf J. L. Loosveld,Jan Willem B. de Groot,Helga Droogendijk,Helgi H. Helgason,Mathijs P. Hendriks,Joost M. Klaase,Geert Kazemier,Mike S. L. Liem,Arjen M. Rijken,Cornelis Verhoef,Johannes H. W. de Wilt,Koert P. Jong,Michael F. Gerhards,Martinus J. van Amerongen,Marc R. W. Engelbrecht,Krijn P. van Lienden,I. Quintus Molenaar,Bart de Valk,Brigitte C. M. Haberkorn,Emile D. Kerver,Frans Erdkamp,Robbert J. van Alphen,Danielle Mathijssen-van Stein,Aysun Komurcu,Marta Lopez-Yurda,Rutger-Jan Swijnenburg,Cornelis J. A. PuntThe Lancet Oncology（2023）引用 7|浏览18暂无评分关键词colorectal cancer,systemic treatment strategies,metastases,liver,first-line,open-labelAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
